This is a Scorecard review, revisiting a past LF0 research call against what actually happened.
Ticker: LRCX Rating: Sell Published: 2026-08-16 Checkpoint: 2026-11-16 Entry price: $343.48 Latest price: $225.92 as of 2026-11-13 Stock return since entry: -34.2% Signal return: +34.2% Verdict: Correct so far
This is the 3-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.
Previous checkpoint: our 2-month review (2026-10-16) was correct (stock return -23.2% since entry). Each monthly review is judged on its own date, so the verdict can change from one month to the next.
Read the original LF0 analysis
What I Said
I rated LRCX a Sell because the stock was already pricing in a lot of good news, with a 46.5x forward P/E, 65.1x EV/EBITDA, and just a 0.9% FCF yield leaving little room for disappointment if semiconductor spending cooled. I also said I would become more constructive only if revenue stayed above $5.8B and operating margin held above 30.0%, while a drop back below $5.3B or a margin break under 30.0% would argue the multiple was too rich.
Peer Comparison
| Company | Return Since Entry |
|---|---|
| LRCX (this call) | -34.2% |
| AMAT | -30.7% |
| KLAC | -26.0% |
How Other Analysts Rate It
Every Wall Street rating action logged on Yahoo Finance since our Sell on 2026-08-17, one row per action (a firm that updates three times appears three times). LF0 rows are in bold.
| Date | Firm | Rating | Action | Price target |
|---|---|---|---|---|
| 2026-08-17 | LF0 Equity Research | Sell | Original call at $343.48 | |
| 2026-08-25 | Mizuho | Outperform | Reiterated | $365.00 (from $370.00) |
| 2026-09-01 | UBS | Buy | Reiterated | $425.00 (from $435.00) |
| 2026-09-16 | LF0 Equity Research | Sell | 1-month update | |
| 2026-10-01 | B. Riley Securities | Buy | Reiterated | $390.00 (from $350.00) |
| 2026-10-05 | Morgan Stanley | Overweight | Reiterated | $385.00 (from $367.00) |
| 2026-10-16 | LF0 Equity Research | Sell | 2-month update | |
| 2026-10-20 | Evercore ISI Group | Outperform | Reiterated | $315.00 (from $355.00) |
| 2026-10-22 | Citigroup | Buy | Reiterated | $435.00 (from $450.00) |
| 2026-10-22 | Mizuho | Outperform | Reiterated | $360.00 (from $365.00) |
| 2026-10-22 | Morgan Stanley | Overweight | Reiterated | $339.00 (from $385.00) |
| 2026-10-22 | Needham | Buy | Reiterated | $290.00 (from $390.00) |
| 2026-10-22 | UBS | Buy | Reiterated | $400.00 (from $425.00) |
| 2026-11-09 | B. Riley Securities | Buy | Reiterated | $310.00 (from $338.00) |
| 2026-11-16 | LF0 Equity Research | Sell | 3-month update (this report) |
No analyst changed their rating on this stock since our Sell on 2026-08-17; the table shows reiterations and price-target changes only.
7 firms still Buy-rated against our call at their latest action: Mizuho, UBS, B. Riley Securities, Morgan Stanley, Evercore ISI Group, Citigroup and Needham.
Counting each firm’s latest action in this window: 7 bullish, 0 neutral, 0 bearish out of 7 firms.
Yahoo’s consensus tally today: 30 Buy, 4 Hold, 0 Sell; three months ago: 29 Buy, 6 Hold, 0 Sell.
Source: Yahoo Finance analyst rating actions. Dates are when Yahoo logged the action. Analyst ratings are third-party opinions, not LF0 views or recommendations.
Why It’s Working (Or Not)
Over this tracking window, following my Sell would have earned 34.2%, which means the short case has worked in the direction I expected. LRCX has fallen sharply from my entry price, and that move has come alongside peers like AMAT and KLAC also moving lower, so the whole group has been weak rather than LRCX simply drifting with a stronger peer set. That supports my original point that the stock was priced for a very strong outcome and had limited margin for error. The price action is consistent with my warning that the valuation could not absorb any cooling in the cycle.
What Could Still Prove Me Wrong
Because the review window is still active, I would be wrong if LRCX reclaims and sustains a much higher level from here while the market starts treating the current valuation as justified rather than stretched. More specifically, if the company continues to show revenue above $5.8B and operating margin above 30.0% while the stock stabilizes or reverses materially, that would weaken my original Sell thesis. A move back toward the high-$8s in forward EPS would also make the premium look more defensible and would force me to reassess.
The August 2026 Cohort
Other directional calls published the same month:
| Ticker | Rating | Entry | Latest | Stock Return | Signal Return | Verdict |
|---|---|---|---|---|---|---|
| SDGR | Sell | $17.40 | $29.53 | +69.7% | -69.7% | Incorrect so far |
| GTN | Sell | $4.83 | $5.99 | +24.0% | -24.0% | Incorrect so far |
| NUTX | Buy | $188.41 | $173.67 | -7.8% | -7.8% | Incorrect so far |
| LHX | Sell | $260.92 | $272.35 | +4.4% | -4.4% | Incorrect so far |
| VNOM | Sell | $41.16 | $42.34 | +2.9% | -2.9% | Incorrect so far |
| AES | Sell | $14.54 | $14.91 | +2.6% | -2.6% | Incorrect so far |
| PENN | Sell | $18.56 | $17.50 | -5.7% | +5.7% | Correct so far |
| RRGB | Sell | $9.51 | $8.81 | -7.4% | +7.4% | Correct so far |
| SPHR | Sell | $147.34 | $125.56 | -14.8% | +14.8% | Correct so far |
| BA | Sell | $210.46 | $171.50 | -18.5% | +18.5% | Correct so far |
| NNDM | Sell | $1.65 | $1.24 | -24.8% | +24.8% | Correct so far |
| NXE | Sell | $10.40 | $7.76 | -25.4% | +25.4% | Correct so far |
| OI | Sell | $6.79 | $4.96 | -27.0% | +27.0% | Correct so far |
| WGS | Sell | $77.88 | $52.37 | -32.8% | +32.8% | Correct so far |
| ADTN | Sell | $7.76 | $4.83 | -37.8% | +37.8% | Correct so far |
| STXS | Sell | $1.39 | $0.84 | -39.6% | +39.6% | Correct so far |
| OWLT | Sell | $5.81 | $3.44 | -40.8% | +40.8% | Correct so far |
| SRG | Strong Sell | $2.11 | $1.52 | -28.0% | +41.9% | Correct so far |
Sector Scorecard: Technology
How are our Technology calls doing overall, and where does LRCX sit among them?
| Peer call | Rating | Published | Signal return |
|---|---|---|---|
| CIFR | Sell | 2026-07-08 | +68.6% |
| INOD | Strong Sell | 2026-10-10 | +61.2% |
| UMAC | Strong Sell | 2026-10-14 | +54.6% |
| SOUN | Sell | 2026-06-14 | +52.4% |
| AEHR | Sell | 2026-06-18 | +50.6% |
| SMTC | Strong Sell | 2026-10-13 | +50.5% |
| AMKR | Sell | 2026-07-27 | +40.4% |
| ICHR | Sell | 2026-09-27 | +39.9% |
We led with Technology, where our 25 calls posted a 92% hit rate and a +27.9% average signal return, with CIFR +68.6% as the best call and NLST -107.0% as the worst. Industrials followed at 81% and +21.4%, while Financial Services was 100% on 5 calls at +18.9%; thin sectors were not ranked, including Utilities with 3 calls at 33% and +17.2%. At the other end, Healthcare lagged among the larger books at 58% and +6.3%, and Communication Services was 60% at +4.1%, while the best hit rates were in Financial Services and Consumer Cyclical at 100%.
Sector League Table
| Sector | Calls | Hit rate | Avg signal return | Best | Worst |
|---|---|---|---|---|---|
| Technology | 25 | 92% | +27.9% | CIFR +68.6% | NLST -107.0% |
| Industrials | 16 | 81% | +21.4% | BW +74.3% | LUNR -35.4% |
| Financial Services | 5 | 100% | +18.9% | HUT +41.5% | BMNR +0.9% |
| Utilities | 3 | 33% | +17.2% | FLNC +67.5% | TLN -13.3% |
| Basic Materials | 5 | 80% | +14.1% | LAR +45.1% | MP -5.2% |
| Consumer Cyclical | 4 | 100% | +10.3% | OI +27.0% | FLUT +1.2% |
| Energy | 6 | 67% | +9.4% | BORR +23.0% | SM -18.9% |
| Healthcare | 12 | 58% | +6.3% | OWLT +40.8% | SDGR -69.7% |
| Communication Services | 5 | 60% | +4.1% | LUMN +39.7% | GTN -24.0% |
| Real Estate* | 2 | 50% | +10.6% | SRG +41.9% | SKYH -20.7% |
| Consumer Defensive* | 1 | 0% | -1.6% | PG -1.6% | PG -1.6% |
| Unclassified* | 2 | 50% | -7.6% | NXE +25.4% | FISV -40.5% |
\* Fewer than 3 calls: not ranked.
Sector by Publish Month
| Sector | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 | Nov 2026 |
|---|---|---|---|---|---|---|
| Technology | +51.5% (2) | +12.1% (7) | +32.3% (3) | +30.2% (6) | +33.1% (7) | — |
| Industrials | +74.3% (1) | +43.7% (5) | +7.1% (2) | +8.8% (3) | +4.3% (3) | -1.8% (2) |
| Healthcare | -5.1% (1) | — | +7.1% (5) | +40.2% (1) | -2.9% (3) | +6.8% (2) |
| Energy | — | +19.1% (1) | -2.9% (1) | +23.0% (1) | +5.8% (3) | — |
| Financial Services | — | +27.5% (3) | — | — | +8.4% (1) | +3.8% (1) |
| Communication Services | — | +8.0% (1) | -4.6% (2) | -17.7% (1) | +39.7% (1) | — |
| Basic Materials | — | +1.8% (1) | — | +45.1% (1) | +14.4% (2) | -5.2% (1) |
| Consumer Cyclical | — | — | +13.3% (3) | — | — | +1.2% (1) |
| Utilities | — | +67.5% (1) | -2.6% (1) | — | -13.3% (1) | — |
| Unclassified | — | — | +25.4% (1) | — | -40.5% (1) | — |
| Real Estate | -20.7% (1) | — | +41.9% (1) | — | — | — |
| Consumer Defensive | — | — | — | — | — | -1.6% (1) |
Each cell: average signal return to date of the calls published that month (calls in brackets). Signal return is direction-adjusted, so a positive number means our call is right.
Live LF0 scorecard: The Scorecard | Research Performance dashboard
Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.
Leave a Comment